Bie-Jia-Jian Pill: Inhibiting Tumor Glycolysis and Promoting CD8+ Cell-Mediated anti-tumor Immunity by Targeting HIF-1α-PI3K/AKT/mTOR and CCL20 in Hepatocellular Carcinoma - PubMed
2 months ago
- #Traditional Medicine
- #Immunotherapy
- #Hepatocellular Carcinoma
- 鳖甲煎丸（BJJP）通过抑制肝细胞癌（HCC）中的Warburg效应增强抗肿瘤免疫力
- 该药物可抑制HCC细胞增殖、生长和迁移，同时促进细胞凋亡并降低PD-L1表达
- 通过增强CD8+ T细胞毒性和肿瘤浸润，与PD-L1阻断疗法产生协同增效作用
- 靶向HIF-1α-PI3K/AKT/mTOR轴重编程肿瘤糖酵解，减少乳酸蓄积和CD8+ T细胞耗竭
- 抑制NF-κB活化并下调CCL20，缓解其对CD8+ T细胞的抑制作用
- 联合免疫治疗可通过调节肿瘤微环境显著改善疗效